Waagsbø, Bjørn
Tranung, Morten
Damås, Jan Kristian
Heggelund, Lars
Funding for this research was provided by:
NTNU Norwegian University of Science and Technology
Article History
Received: 21 May 2022
Revised: 9 September 2022
Accepted: 26 September 2022
First Online: 14 October 2022
Declarations
:
: The protocol for each study year was evaluated and approved by the Regional Committees for Medical and Health Research Ethics, Norwegian University of Science and Technology NTNU/Regional Ethic Committee Central, Faculty of Medicine, Pb 8905, 7491 Trondheim. Approval number was 2017/1439, head of secretariat Hilde Eikemo. Data protection officials, and the hospital administration also approved the study. The study was conducted in line with the conclusion from the Regional Committees for Medical and Health Research Ethics, Central, that informed consents were not required to access or publish the data. An informed consent waiver was obtained from the St. Olavs hospital, Trondheim University Hospital. This consent waiver was evaluated by the Regional Committees for Medical and Health Research Central, before approval of the study. Consent to participate was not obtained. The study was conducted in accordance with the principles of the Declaration of Helsinki, and the guidelines for medical and health research from The Norwegian National Research Ethics Committees.
: Not applicable.
: Author Bjørn Waagsbø is a representative to the directory group in the Norwegian Directorate of Health that seek to revise recommendations in the national clinical practice guideline for antimicrobial therapy.
: None to declare.